Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Precision Medicine, Cancer
        The future of precision medicine: integrating functional approaches for better outcomes.
            April 4, 2024 -
            4 min read
          
          
         
      Precision Medicine
        Redefining precision medicine with real-time insights.
            April 4, 2024 -
            2 min read
          
          
         
      Precision Medicine, Physiological Model Solutions, Cancer
        Precision medicine boosted by functional drug testing using patient-derived model systems.
            April 4, 2024 -
            2 min read
          
          
         
       
      Small Molecule Drug Discovery
        Novel therapeutic candidate puts the STING back into immunotherapy.
            April 4, 2024 -
            3 min read
          
          
         
      Disease Research
        REVIEW: Bioluminescent-based in vivo imaging of glucose uptake.
            April 3, 2024 -
            3 min read
          
          
         
       
      Disease Research, Drug Development
        Seven steps to designing an effective in vivo fluorescence imaging study.
            April 3, 2024 -
            2 min read
          
          
         
      Cancer
        How ultrasound may predict tumor response to therapy earlier.
            April 3, 2024 -
            2 min read
          
          
         
      Cardiovascular disease research, Disease Research
        Expanding cardiovascular research: an innovative approach to evaluating pulmonary arterial hypertension.
            April 3, 2024 -
            4 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  